Understanding the biology of non-mhc-restricted cytotoxicity: toward new approaches in the treatment of cancer?
Michon
J M
JM
Service d'Oncologie Pediatrique, Institut Curie, 26 rue d'Ulm, Paris.
Fridman
W H
WH
D006801:Humans; D007376:Interleukin-2 / Q000494:pharmacology*; D007694:Killer Cells, Natural / Q000276:immunology*; D008285:Major Histocompatibility Complex; D009369:Neoplasms / Q000628:therapy*; D011961:Receptors, Fc / Q000276:immunology; D013602:T-Lymphocytes, Cytotoxic / Q000502:physiology*; D014407:Tumor Cells, Cultured / Q000276:immunology
D007376:Interleukin-2; D011961:Receptors, Fc